Mutations of KRAS observed in pancreatic cancers often occur in codons 12, 13, and 61, at most are G12D or G12R substitutions, which attenuates the intrinsic GTPase activity, thus, such mutations result in prolonged activation of RAS (6). Here, KRAS is linked to familial pancreatic carcinoma.